{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:59:20Z","timestamp":1793224760974,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01345-4","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:04:03Z","timestamp":1778040243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Individual cases of Parkinson\u2019s disease can be robustly classified using magnetoencephalography"],"prefix":"10.1038","volume":"12","author":[{"given":"Gillian","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Dunkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"1345_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","volume":"72","author":"CW Olanow","year":"2009","unstructured":"Olanow, C. W., Stern, M. B. & Sethi, K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology 72, S1\u2013S136 (2009). (2009).","journal-title":"Neurology"},{"key":"1345_CR2","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su, D. et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. Br. Med. J. 388, e080952 (2025).","journal-title":"Br. Med. J."},{"key":"1345_CR3","first-page":"501","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: what\u2019s the difference? J. Park. Dis. 9, 501\u2013515 (2019).","journal-title":"J. Park. Dis."},{"key":"1345_CR4","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier, D. J. Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J. 285, 3657\u20133668 (2018).","journal-title":"FEBS J."},{"key":"1345_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D Aarsland","year":"2005","unstructured":"Aarsland, D., Zaccai, J. & Brayne, C. A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov. Disord. 20, 1255\u20131263 (2005).","journal-title":"Mov. Disord."},{"key":"1345_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa, E., Garrido, A., Scholz, S. W. & Poewe, W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 20, 385\u2013397 (2021).","journal-title":"Lancet Neurol."},{"key":"1345_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh, F. N. & Surguchov, A. Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front. Neurosci. 12, 612 (2018).","journal-title":"Front. Neurosci."},{"key":"1345_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali, A., Thomas, G. E. C., Zetterberg, H. & Weil, R. S. Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat. Commun. 15, 5661 (2024).","journal-title":"Nat. Commun."},{"key":"1345_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41531-021-00185-8","volume":"7","author":"D Bega","year":"2021","unstructured":"Bega, D. et al. Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. NPJ Park. Dis. 7, 43 (2021).","journal-title":"NPJ Park. Dis."},{"key":"1345_CR10","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.1807983116","volume":"116","author":"CM Cassidy","year":"2019","unstructured":"Cassidy, C. M. et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc. Natl. Acad. Sci. USA 116, 5108\u20135117 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1345_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","volume":"31","author":"SJ Cho","year":"2021","unstructured":"Cho, S. J. et al. Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis. Eur. Radiol. 31, 1268\u20131280 (2021).","journal-title":"Eur. Radiol."},{"key":"1345_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1103\/RevModPhys.65.413","volume":"65","author":"M H\u00e4m\u00e4l\u00e4inen","year":"1993","unstructured":"H\u00e4m\u00e4l\u00e4inen, M., Hari, R., Ilmoniemi, R., Knuutila, J. & Lounasmaa, O. V. Magnetoencephalography-theory, instrumentation, and applications to noninvasive studies of the working human brain. Rev. Mod. Phys. 65, 413\u2013497 (1993).","journal-title":"Rev. Mod. Phys."},{"key":"1345_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70889","volume":"15","author":"S Kariv","year":"2025","unstructured":"Kariv, S. et al. Using magnetoencephalography to advance the science of Parkinson disease: a systematic review. Brain Behav. 15, e70889 (2025).","journal-title":"Brain Behav."},{"key":"1345_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.neuroimage.2006.06.005","volume":"32","author":"MT Jurkiewicz","year":"2006","unstructured":"Jurkiewicz, M. T., Gaetz, W. C., Bostan, A. C. & Cheyne, D. Post-movement beta rebound is generated in motor cortex: evidence from neuromagnetic recordings. NeuroImage 32, 1281\u20131289 (2006).","journal-title":"NeuroImage"},{"key":"1345_CR15","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/hbm.24562","volume":"40","author":"LI Boon","year":"2019","unstructured":"Boon, L. I. et al. A systematic review of MEG-based studies in Parkinson\u2019s disease: the motor system and beyond. Hum. Brain Mapp. 40, 2827\u20132848 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"1345_CR16","doi-asserted-by":"crossref","unstructured":"Pollok, B. et al. Motor-cortical oscillations in early stages of Parkinson\u2019s disease. J. Physiol. 590, 3203\u20133212 (2012).","DOI":"10.1113\/jphysiol.2012.231316"},{"key":"1345_CR17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1152\/jn.00383.2014","volume":"112","author":"E Heinrichs-Graham","year":"2014","unstructured":"Heinrichs-Graham, E. et al. Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson\u2019s disease: a pharmaco-magnetoencephalography study. J. Neurophysiol. 112, 1739\u20131747 (2014).","journal-title":"J. Neurophysiol."},{"key":"1345_CR18","doi-asserted-by":"crossref","unstructured":"Donoghue, T., Dominguez, J. & Voytek, B. Electrophysiological frequency band ratio measures conflate periodic and aperiodic neural activity. eNeuro 7 (2020).","DOI":"10.1101\/2020.01.11.900977"},{"key":"1345_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/psyp.14478","volume":"61","author":"DJ McKeown","year":"2024","unstructured":"McKeown, D. J. et al. Medication-invariant resting aperiodic and periodic neural activity in Parkinson\u2019s disease. Psychophysiology 61, e14478 (2024).","journal-title":"Psychophysiology"},{"key":"1345_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","volume":"115","author":"J Jeong","year":"2004","unstructured":"Jeong, J. EEG dynamics in patients with Alzheimer\u2019s disease. Clin. Neurophysiol. 115, 1490\u20131505 (2004).","journal-title":"Clin. Neurophysiol."},{"key":"1345_CR21","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/brain\/awm034","volume":"130","author":"D Stoffers","year":"2007","unstructured":"Stoffers, D. et al. Slowing of oscillatory brain activity is a stable characteristic of Parkinson\u2019s disease without dementia. Brain 130, 1847\u20131860 (2007).","journal-title":"Brain"},{"key":"1345_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13195-022-01041-4","volume":"14","author":"AM van Nifterick","year":"2022","unstructured":"van Nifterick, A. M. et al. A multiscale brain network model links Alzheimer\u2019s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing. Alzheimers Res. Ther. 14, 101 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"1345_CR23","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/brain\/awab430","volume":"145","author":"A Wiesman","year":"2022","unstructured":"Wiesman, A. et al. Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer\u2019s disease. Brain 145, 2177\u20132189 (2022).","journal-title":"Brain"},{"key":"1345_CR24","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","volume":"4","author":"AAHde Hond","year":"2022","unstructured":"Hond, A. A. H. de, Steyerberg, E. W. & van Calster, B. Interpreting area under the receiver operating characteristic curve. Lancet Digit. Health 4, e853\u2013e855 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1345_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.1988.tb03609.x","volume":"78","author":"MY Neufeld","year":"1988","unstructured":"Neufeld, M. Y., Inzelberg, R. & Korczyn, A. D. EEG in demented and non-demented Parkinsonian patients. Acta Neurol. Scand. 78, 1\u20135 (1988).","journal-title":"Acta Neurol. Scand."},{"key":"1345_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0013-4694(91)90134-P","volume":"79","author":"R Soikkeli","year":"1991","unstructured":"Soikkeli, R., Partanen, J., Soininen, H., P\u00e4\u00e4kk\u00f6nen, A. & Riekkinen, P. Slowing of EEG in Parkinson\u2019s disease. Electroencephalogr. Clin. Neurophysiol. 79, 159\u2013165 (1991).","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"1345_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/155005948902000204","volume":"20","author":"JR Hughes","year":"1989","unstructured":"Hughes, J. R., Shanmugham, S., Wetzel, L. C., Bellur, S. & Hughes, C. A. The relationship between EEG changes and cognitive functions in dementia: a study in a VA population. Clin. EEG Electroencephalogr. 20, 77\u201385 (1989).","journal-title":"Clin. EEG Electroencephalogr."},{"key":"1345_CR28","doi-asserted-by":"publisher","first-page":"102538","DOI":"10.1016\/j.pneurobio.2023.102538","volume":"231","author":"AI Wiesman","year":"2023","unstructured":"Wiesman, A. I. et al. Adverse and compensatory neurophysiological slowing in Parkinson\u2019s disease. Prog. Neurobiol. 231, 102538 (2023).","journal-title":"Prog. Neurobiol."},{"key":"1345_CR29","doi-asserted-by":"publisher","first-page":"879716","DOI":"10.1155\/2011\/879716","volume":"2011","author":"F Tadel","year":"2011","unstructured":"Tadel, F., Baillet, S., Mosher, J. C., Pantazis, D. & Leahy, R. M. Brainstorm: a user-friendly application for MEG\/EEG analysis. Comput. Intell. Neurosci. 2011, 879716 (2011).","journal-title":"Comput. Intell. Neurosci."},{"key":"1345_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1212\/WNL.0b013e318224af8d","volume":"77","author":"BT Klassen","year":"2011","unstructured":"Klassen, B. T. et al. Quantitative EEG as a predictive biomarker for Parkinson disease dementia. Neurology 77, 118\u2013124 (2011).","journal-title":"Neurology"},{"key":"1345_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1212\/WNL.0000000000000034","volume":"82","author":"KTE Olde Dubbelink","year":"2014","unstructured":"Olde Dubbelink, K. T. E. et al. Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers. Neurology 82, 263\u2013270 (2014).","journal-title":"Neurology"},{"key":"1345_CR32","first-page":"117","volume":"5","author":"JN Caviness","year":"2015","unstructured":"Caviness, J. N. et al. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson\u2019s disease. J. Park. Dis. 5, 117\u2013124 (2015).","journal-title":"J. Park. Dis."},{"key":"1345_CR33","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s10439-011-0416-0","volume":"39","author":"C G\u00f3mez","year":"2011","unstructured":"G\u00f3mez, C. et al. Complexity analysis of resting-state MEG activity in early-stage Parkinson\u2019s disease patients. Ann. Biomed. Eng. 39, 2935\u20132944 (2011).","journal-title":"Ann. Biomed. Eng."},{"key":"1345_CR34","doi-asserted-by":"publisher","first-page":"10927","DOI":"10.1007\/s00521-018-3689-5","volume":"32","author":"SL Oh","year":"2020","unstructured":"Oh, S. L. et al. A deep learning approach for Parkinson\u2019s disease diagnosis from EEG signals. Neural Comput. Appl. 32, 10927\u201310933 (2020).","journal-title":"Neural Comput. Appl."},{"key":"1345_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2020.08.001","volume":"79","author":"MF Anjum","year":"2020","unstructured":"Anjum, M. F. et al. Linear predictive coding distinguishes spectral EEG features of Parkinson\u2019s disease. Parkinsonism Relat. Disord. 79, 79\u201385 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1345_CR36","doi-asserted-by":"publisher","first-page":"17017","DOI":"10.1109\/JSEN.2021.3080135","volume":"21","author":"SK Khare","year":"2021","unstructured":"Khare, S. K., Bajaj, V. & Acharya, U. R. PDCNNet: An Automatic Framework for the Detection of Parkinson\u2019s Disease Using EEG Signals. IEEE Sens. J. 21, 17017\u201317024 (2021).","journal-title":"IEEE Sens. J."},{"key":"1345_CR37","doi-asserted-by":"publisher","first-page":"109282","DOI":"10.1016\/j.jneumeth.2021.109282","volume":"361","author":"S Lee","year":"2021","unstructured":"Lee, S., Hussein, R., Ward, R., Jane Wang, Z. & McKeown, M. J. A convolutional-recurrent neural network approach to resting-state EEG classification in Parkinson\u2019s disease. J. Neurosci. Methods 361, 109282 (2021).","journal-title":"J. Neurosci. Methods"},{"key":"1345_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00521-016-2756-z","volume":"30","author":"R Yuvaraj","year":"2018","unstructured":"Yuvaraj, R., Rajendra Acharya, U. & Hagiwara, Y. A novel Parkinson\u2019s Disease Diagnosis Index using higher-order spectra features in EEG signals. Neural Comput. Appl. 30, 1225\u20131235 (2018).","journal-title":"Neural Comput. Appl."},{"key":"1345_CR39","doi-asserted-by":"publisher","first-page":"7615","DOI":"10.1007\/s00521-020-05505-2","volume":"33","author":"SA Khoshnevis","year":"2021","unstructured":"Khoshnevis, S. A. & Sankar, R. Classification of the stages of Parkinson\u2019s disease using novel higher-order statistical features of EEG signals. Neural Comput. Appl. 33, 7615\u20137627 (2021).","journal-title":"Neural Comput. Appl."},{"key":"1345_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/WNL.0000000000006473","volume":"91","author":"VJ Geraedts","year":"2018","unstructured":"Geraedts, V. J. et al. Clinical correlates of quantitative EEG in Parkinson disease. Neurology 91, 871\u2013883 (2018).","journal-title":"Neurology"},{"key":"1345_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54055","volume":"9","author":"DA Engemann","year":"2020","unstructured":"Engemann, D. A. et al. Combining magnetoencephalography with magnetic resonance imaging enhances learning of surrogate-biomarkers. eLife 9, e54055 (2020).","journal-title":"eLife"},{"key":"1345_CR42","doi-asserted-by":"crossref","unstructured":"da Silva Castanheira, J., Wiesman, A. I., Hansen, J. Y., Misic, B. & Baillet, S. The neurophysiological brain-fingerprint of Parkinson\u2019s disease. EbioMedicine 105, 1\u201318 (2024).","DOI":"10.1101\/2023.02.03.23285441"},{"key":"1345_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroimage.2012.10.001","volume":"65","author":"J Gross","year":"2013","unstructured":"Gross, J. et al. Good practice for conducting and reporting MEG research. NeuroImage 65, 349\u2013363 (2013).","journal-title":"NeuroImage"},{"key":"1345_CR44","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.neuroimage.2015.04.028","volume":"124","author":"G Niso","year":"2016","unstructured":"Niso, G. et al. OMEGA: the Open MEG Archive. NeuroImage 124, 1182\u20131187 (2016).","journal-title":"NeuroImage"},{"key":"1345_CR45","doi-asserted-by":"crossref","unstructured":"Gramfort, A. et al. MEG and EEG data analysis with MNE-Python. Front. Neurosci. 7, 1\u201313 (2013).","DOI":"10.3389\/fnins.2013.00267"},{"key":"1345_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/imag_a_00195","volume":"2","author":"S Hardy","year":"2024","unstructured":"Hardy, S., Roberts, G., Ventresca, M. & Dunkley, B. T. Predicting brain age across the adult lifespan with spontaneous oscillations and functional coupling in resting brain networks captured with magnetoencephalography. Imaging Neurosci 2, 1\u201317 (2024).","journal-title":"Imaging Neurosci"},{"key":"1345_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hbm.460020402","volume":"2","author":"KJ Friston","year":"1994","unstructured":"Friston, K. J. et al. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2, 189\u2013210 (1994).","journal-title":"Hum. Brain Mapp."},{"key":"1345_CR48","doi-asserted-by":"publisher","unstructured":"Quinn, A. J. et al. The GLM-Spectrum: a multilevel framework for spectrum analysis with covariate and confound modelling. Imaging Neurosci. https:\/\/doi.org\/10.1162\/imag_a_00082 (2024).","DOI":"10.1162\/imag_a_00082"},{"key":"1345_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119595","volume":"263","author":"C Gohil","year":"2022","unstructured":"Gohil, C. et al. Mixtures of large-scale dynamic functional brain network modes. NeuroImage 263, 119595 (2022).","journal-title":"NeuroImage"},{"key":"1345_CR50","unstructured":"Wegelin, J. A survey of partial least squares (PLS) methods, with emphasis on the two-block case. Tech. Rep. 371, 1\u201344 (2000)."},{"key":"1345_CR51","doi-asserted-by":"publisher","unstructured":"Abdi, H. & Williams, L. J. Partial least squares methods: partial least squares correlation and partial least square regression. in Computational Toxicology: Volume II (eds Reisfeld, B. & Mayeno, A. N.) pp 549\u2013579 (Humana Press, Totowa, NJ, 2013). https:\/\/doi.org\/10.1007\/978-1-62703-059-5_23.","DOI":"10.1007\/978-1-62703-059-5_23"},{"key":"1345_CR52","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1039\/C8AN00599K","volume":"143","author":"LC Lee","year":"2018","unstructured":"Lee, L. C., Liong, C.-Y. & Jemain, A. A. Partial least squares-discriminant analysis (PLS-DA) for classification of high-dimensional (HD) data: a review of contemporary practice strategies and knowledge gaps. The Analyst 143, 3526\u20133539 (2018).","journal-title":"The Analyst"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01345-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:02:42Z","timestamp":1783645362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01345-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01345-4","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.R. and S.H. are employees of MYndspan Ltd., a neurotechnology company. B.D. is Chief Scientific Officer of MYndspan Ltd. Y.P. receives consultancy payments from MYndspan for their work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}